Dr. Neir Eshel (he/him/his) is a tenure-track Assistant Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. His clinical focus is the full-spectrum mental health care of sexual and gender minorities, with particular interest in depression, anxiety, and the complex effects of trauma in this population. He works in collaboration with other primary care and mental health providers at the new Stanford LGBTQ+ program.
Dr. Nathanael Gray's Laboratory develops first-in-class chemical probes that are used to gain new biological insights into cellular processes that drive cancer and other diseases, and to pharmacologically validate potential clinically relevant targets. They take an integrative approach that combines medicinal chemistry, structural biology, biochemistry and molecular and cell biology to develop new therapeutic strategies. Their work has contributed to several approved and clinical stage drugs targeting BCR-ABL, Sphingosine-1-phosphate receptor (S1PR), EGFR, EML4-ALK and CDK7.
Dr. Nathan Reticker-Flynn is a Biomedical Engineer and tumor immunologist working at the interfaces of cancer metastasis, tumor evolution, adaptive immunity, and immuno-oncology. His work employs mouse models and systems biology and genetic engineering to investigate interactions between tumors and the immune system during cancer metastasis. He performed his PhD work in Biomedical Engineering with Dr. Sangeeta Bhatia at MIT where he studied glycobiology and ECM interactions during cancer metastasis and his postdoctoral studies with Dr.
Dr. Nathan Lo is an Assistant Professor of Infectious Diseases. His research group studies the transmission of infectious diseases and impact of public health strategies with an ultimate goal of informing public health policy. His research blends diverse computational methodologies, including tools of epidemiology, modeling, pathogen genomics, and policy analysis. His interest spans across multiple infectious diseases including neglected tropical diseases, vaccine-preventable infections, and COVID-19.
Dr. Natalie Torok's lab investigates the molecular mechanisms of liver fibrosis, focusing on the role of oxidative pathways in non-alcoholic and alcoholic steatohepatitis.
Dr. Torok's lab has demonstrated the intricate link between hepatocyte cell death, generation of apoptotic bodies and their phagocytosis by stellate cells triggering fibrogenic activation. Key to this was the activation of the NADPH oxidase and production of reactive oxidative species inducing stellate cell transdifferentiation and collagen I transcription.
Dr. Natalie Larson's lab develops hybrid manufacturing methods (e.g., multimaterial 3D printing with subvoxel control) and applies in-situ characterization techniques (e.g., 4D X-ray computed tomography) to investigate new classes of hierarchical architected materials. The Lab aims to enable sustainable fabrication of multimaterial and composite systems with enhanced properties, including efficiency and multifunctionality, for applications in aerospace, transportation, soft robotics, and healthcare.
Dr. Natalia Serna is an Assistant Professor in the Department of Health Policy at Stanford University and a SIEPR and Stanford Global Health Faculty Fellow.
Dr. Serna's research agenda lies at the intersection of industrial organization of health care markets and health outcomes research. She is specifically interested in how health insurance plan design affects patient outcomes and doctor decision making.
